Skip to main content

Nonfunctioning Pituitary Adenoma: Management

  • Chapter
  • First Online:
Pituitary Tumors
  • 497 Accesses

Abstract

Since nonfunctioning pituitary adenomas do not present with a clinical syndrome of pituitary hormone excess, common presentations include neurologic symptoms such as visual impairment and/or headache, symptoms of pituitary hormone deficiency, or an incidental sellar mass on an imaging study. The evaluation of a newly diagnosed pituitary adenoma should include a detailed history and physical exam, a dedicated pituitary MRI, biochemical evaluation of pituitary hormone excess and deficiency, and visual field and acuity testing if clinically indicated. Vision impairment due to optic chiasm compression is a clear indication for transsphenoidal surgery. Transsphenoidal surgery may also be considered in cases of high risk of visual impairment, clinically significant tumor growth, and/or hypopituitarism. Transsphenoidal surgery is typically successful in reducing tumor volume and improving vision and is less successful in reversing hypopituitarism. If there is little or no residual adenoma on pituitary MRI, the patient should still be monitored for recurrence with serial pituitary MRI scans. If there is significant residual adenoma on pituitary MRI or progressive adenoma regrowth after surgery, postoperative radiation therapy may be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro-oncology. 2001;3(3):141–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Popovic V, Damjanovic S. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors. Thyroid. 1998;8(10):935–9. https://doi.org/10.1089/thy.1998.8.935.

    Article  PubMed  CAS  Google Scholar 

  3. Rajasekaran S, Vanderpump M, Baldeweg S, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011;74(1):9–20. https://doi.org/10.1111/j.1365-2265.2010.03913.x.

    Article  Google Scholar 

  4. Fatemi N, Dusick JR, Mattozo C, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63(4):709–718; discussion 718–9. https://doi.org/10.1227/01.NEU.0000325725.77132.90.

    Article  PubMed  Google Scholar 

  5. Webb SM, Rigla M, Wägner A, Oliver B, Bartumeus F. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab. 1999;84(10):3696–700. https://doi.org/10.1210/jcem.84.10.6019.

    Article  PubMed  CAS  Google Scholar 

  6. Marazuela M, Astigarraga B, Vicente A, et al. Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest. 1994;17(9):703–7. https://doi.org/10.1007/BF03347763.

    Article  PubMed  CAS  Google Scholar 

  7. Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91(5):1796–801. https://doi.org/10.1210/jc.2005-2552.

    Article  PubMed  CAS  Google Scholar 

  8. Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008;37(1):151–171, xi. https://doi.org/10.1016/j.ecl.2007.10.011.

    Article  PubMed  Google Scholar 

  9. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904. https://doi.org/10.1210/jc.2010-1048.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28(1):81–117, vi.

    Article  CAS  PubMed  Google Scholar 

  11. Karavitaki N, Thanabalasingham G, Shore HCA, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf). 2006;65(4):524–9. https://doi.org/10.1111/j.1365-2265.2006.02627.x.

    Article  CAS  Google Scholar 

  12. Chen L, White WL, Spetzler RF, Xu B. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol. 2011;102(1):129–38. https://doi.org/10.1007/s11060-010-0302-x.

    Article  PubMed  Google Scholar 

  13. Dallapiazza RF, Grober Y, Starke RM, Laws ER, Jane JA. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015;76(1):42–52; discussion 52–3. https://doi.org/10.1227/NEU.0000000000000563.

    Article  PubMed  Google Scholar 

  14. Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M. Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery. 2005;56(6):1222–1233; discussion 1233.

    Article  PubMed  Google Scholar 

  15. Murad MH, Fernández-Balsells MM, Barwise A, et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2010;73(6):777–91. https://doi.org/10.1111/j.1365-2265.2010.03875.x.

    Article  Google Scholar 

  16. Woollons AC, Hunn MK, Rajapakse YR, et al. Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol. 2000;53(6):713–7. https://doi.org/10.1046/j.1365-2265.2000.01153.x.

    Article  CAS  Google Scholar 

  17. Boelaert K, Gittoes NJ. Radiotherapy for non-functioning pituitary adenomas. Eur J Endocrinol. 2001;144(6):569–75.

    Article  CAS  PubMed  Google Scholar 

  18. Greenman Y, Cooper O, Yaish I, et al. Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists. Eur J Endocrinol. 2016;175(1):63–72. https://doi.org/10.1530/EJE-16-0206.

    Article  PubMed  CAS  Google Scholar 

  19. Dekkers OM, Hammer S, de Keizer RJW, et al. The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol. 2007;156(2):217–24. https://doi.org/10.1530/eje.1.02334.

    Article  PubMed  CAS  Google Scholar 

  20. Arita K, Tominaga A, Sugiyama K, et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg. 2006;104(6):884–91. https://doi.org/10.3171/jns.2006.104.6.884.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melanie Schorr .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schorr, M. (2018). Nonfunctioning Pituitary Adenoma: Management. In: Nachtigall, L. (eds) Pituitary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-90909-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90909-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90907-3

  • Online ISBN: 978-3-319-90909-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics